Advaita Bioinformatics Awarded $1.8M for Disease Subtype ID Tech | GenomeWeb

NEW YORK (GenomeWeb) – Advaita Bioinformatics has received a notice of award from the National Institute of General Medical Sciences for a Phase II Small Business Investigational Research grant to develop and implement a new method of identifying disease subtypes and subgroups of patients within disease phenotypes.

The Plymouth, Mich.-based firm will use the three-year, $1.8 million grant also to identify biological pathway signatures for specific diseases and to identify pathway signatures for drugs in order to repurpose them, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.